1. ALK rearrangement in lung adenocarcinoma with concurrent cervix and breast metastases: A case report. Issue 11 (24th August 2018) Authors: Chuang, Xin; Chen, Ying; Yu, Ping; Qiu, Xueshan; Wang, Jian; Qu, Xiujuan; Teng, Yuee; Liu, Yunpeng; Jin, Bo Journal: Thoracic cancer Issue: Volume 9:Issue 11(2018) Page Start: 1513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018). (25th July 2020) Authors: Xu, Binghe; Hu, Xichun; Feng, Jifeng; Geng, Cuizhi; Jin, Feng; Li, Hongyuan; Li, Man; Li, Qing; Liao, Ning; Liu, Donggeng; Liu, Jian; Liu, Qiang; Lu, Jinsong; Liu, Zhenzhen; Ma, Fei; Ouyang, Quchang; Pan, Yueyin; Shen, Kunwei; Sun, Tao; Teng, Yuee Journal: Cancer Issue: Volume 126:(2020)Supplement 16 Page Start: 3867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive /human epidermal growth factor receptor 2 -advanced breast cancer (FRIEND study). (May 2023) Authors: Wang, Jiayu; Cai, Li; Song, Yanqiu; Sun, Tao; Tong, Zhongsheng; Teng, Yuee; Li, Huiping; Ouyang, Quchang; Chen, Qianjun; Cui, Shude; Yin, Yongmei; Liao, Ning; Sun, Qiang; Feng, Jifeng; Wang, Xiaojia; Xu, Binghe Journal: European journal of cancer Issue: Volume 184(2023) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Combination of platelet count and neutrophil–lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival in metastatic advanced gastric cancer. (October 2017) Authors: Wang, Jin; Qu, Jinglei; Li, Zhi; Che, Xiaofang; Liu, Jing; Teng, Yuee; Jin, Bo; Zhao, Mingfang; Zhang, Lingyun; Liu, Yunpeng; Qu, Xiujuan Journal: Biomarkers in medicine Issue: Volume 11:Number 10(2017) Page Start: 835 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FEN1 mediates miR‐200a methylation and promotes breast cancer cell growth via MET and EGFR signaling. Issue 10 (2nd July 2019) Authors: Zeng, Xue; Qu, Xiujuan; Zhao, Chenyang; Xu, Lu; Hou, Kezuo; Liu, Yunpeng; Zhang, Na; Feng, Jing; Shi, Sha; Zhang, Lingyun; Xiao, Jiawen; Guo, Zhigang; Teng, Yuee; Che, Xiaofang Journal: FASEB journal Issue: Volume 33:Issue 10(2019) Page Start: 10717 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. MiR-155-5p antagonizes the apoptotic effect of bufalin in triple-negative breast cancer cells. Issue 1 (January 2016) Authors: Wang, Qian; Li, Ce; Zhu, Zhitu; Teng, Yuee; Che, Xiaofang; Wang, Yan; Ma, Yanju; Wang, Yiding; Zheng, Huachuan; Liu, Yunpeng; Qu, Xiujuan Journal: Anti-cancer drugs Issue: Volume 27:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Natural helper cells mediate respiratory syncytial virus-induced airway inflammation by producing type 2 cytokines in an IL-33-dependent manner. (August 2017) Authors: Han, Xu; Chai, Ruonan; Qi, Feifei; Bai, Song; Cui, Yulin; Teng, Yuee; Liu, Beixing Journal: Immunotherapy Issue: Volume 9:Number 9(2017) Page Start: 715 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pretreatment platelet‐to‐lymphocyte ratio is associated with the response to first‐line chemotherapy and survival in patients with metastatic gastric cancer. Issue 1 (26th February 2017) Authors: Wang, Jin; Qu, Jinglei; Li, Zhi; Che, Xiaofang; Liu, Jing; Teng, Yuee; Jin, Bo; Zhao, Mingfang; Liu, Yunpeng; Qu, Xiujuan Journal: Journal of clinical laboratory analysis Issue: Volume 32:Issue 1(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation‐wide multicenter study. (2nd September 2021) Authors: Guo, Fengzhu; Yi, Zongbi; Wang, Wenna; Han, Yiqun; Yu, Pei; Zhang, Su; Ouyang, Quchang; Yan, Min; Wang, Xiaojia; Hu, Xichun; Jiang, Zefei; Huang, Tao; Tong, Zhongsheng; Wang, Shusen; Yin, Yongmei; Li, Hui; Yang, Runxiang; Yang, Huawei; Teng, Yuee; Sun, Tao Journal: Cancer medicine Issue: Volume 10:Number 19(2021) Page Start: 6744 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Receptor activator for nuclear factor κ B expression predicts poor prognosis in breast cancer patients with bone metastasis but not in patients with visceral metastasis. Issue 1 (2nd November 2011) Authors: Zhang, Lingyun; Teng, Yuee; Zhang, Ye; Liu, Jing; Xu, Ling; Qu, Jinglei; Hou, Kezuo; Yang, Xianghong; Liu, Yunpeng; Qu, Xiujuan Journal: Journal of clinical pathology Issue: Volume 65:Issue 1(2012) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗